drugset / Trial / NCT05151848
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective,open-labelled,multi-center,randomized clinical trial.It compares the clinical efficacy and safety of there 2 drugs in the treatment of relapse active Takayasu's arteritis patients.
Timeline
- Start
- 2022-01-05
- Primary completion
- 2026-01-15
- Completion
- 2026-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |
| Comparator | Tofacitinib | Small molecule | 5 mg | Oral |